The Global Pharmacovigilance Society is a pioneering organization in the field of pharmacovigilance, dedicated to protecting patients from adverse drug reactions and ensuring drug safety. Founded in 2020 and headquartered in India, the society brings together a team of pharmacovigilance professionals and leaders from around the world. Through various initiatives such as webinars, conferences, and the publication of the Journal of Pharmacovigilance and Drug Research (JPADR), they actively contribute to improving patient safety and promoting awareness in the field of pharmacovigilance.
One of the notable aspects of the society is its focus on supporting patients affected by adverse drug reactions, offering ICU, blood bank, and blood donor support. Additionally, their efforts extend to creating awareness among the public for ADR reporting and collaborating with stakeholders in pharmaceutical research and development to enhance the quality of dosage forms. Furthermore, they provide valuable support to students and researchers by offering library resources, free manuscript publications, and opportunities to present their work at international conferences.
With a mission to strengthen the pharmacovigilance system, the Global Pharmacovigilance Society is poised to make a significant impact in the pharmaceutical and publishing industries. Their openness to collaboration with organizations in the pharmacovigilance space demonstrates their commitment to advancing drug safety on a global scale.
There is no investment information